GENE ONLINE|News &
Opinion
Blog

Partnerships
Amgen Lays Down $3.7 Billion For ChemoCentryx and its Autoimmune Portfolio
2022-08-04
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
2022-08-04
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
Nestlé Lays Down €40 Million on Enterome’s Food Allergy and IBD Candidate
2022-07-19
Orion Collects $290 Million From Merck in Prostate Cancer Development Collaboration
2022-07-14
NIH Launches mRNA Nipah Virus Vaccine Trial With Moderna
2022-07-12
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
Gilead Sciences Works Alongside Westminster Drug Project To Eliminate Hepatitis C
2022-06-09
NVIDIA & Singular Genomics Team Up to Boost Next-Gen Sequencing Capabilities
2022-05-11
1 5 6 7
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top